Evidence map›Paper›PMID 34974613›Full record

ArticleEuropean heart journal2022

The year in cardiovascular medicine 2021: interventional cardiology.

Javier Escaned, Farouc A Jaffer, Julinda Mehilli, Roxana Mehran

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Javier EscanedHospital Clínico San Carlos IDISCC, Complutense University of Madrid, Madrid, Spain.ORCID 0000-0003-4932-0112
Farouc A JafferCardiology Division, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.ORCID 0000-0001-7980-384X
Julinda MehilliMedizinische Klinik I, Landshut-Achdorf Hospital, Landshut, Klinikum der Universitaet München, Ludwig-Maximilians-Universitaet and German Centre for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.ORCID 0000-0002-8750-5567
Roxana MehranThe Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-5546-262X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since last year's report in the European Heart Journal, we have witnessed substantial progress in all aspects of interventional cardiology. Of note, the practice of interventional cardiology took place amidst successive waves of the COVID-19 pandemic, which continues to be a major burden for all healthcare professionals around the globe. In our yearly review, we shall revisit the developments in percutaneous coronary intervention (PCI), structural heart interventions, and adjunctive pharmacotherapy.

Indexed as

CardiologyCOVID-19Percutaneous Coronary InterventionHumansPandemicsSARS-CoV-2Antiplatelet agentsCoronary interventionsInterventional cardiologyTranscatheter aortic valve implantation

Identifiers

PMID34974613
PMCPMC9383143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.